Oncolytics receives noncompliance notification from Nasdaq

Oncolytics (ONCY) announced that it received a delinquency notification letter from Nasdaq indicating that the company is not currently in compliance with the minimum bid price requirement set forth in Nasdaq’s Listing Rules for continued listing on the Nasdaq Capital Market, as the closing bid price for the company’s ordinary shares listed on Nasdaq was below $1.00 per share for 30 consecutive business days. The notice provides that the company has a period of 180 calendar days from the date of the Notice, or until August 12 to regain compliance with the minimum bid price requirement.